Patents

Patents. The patents listed in Schedule 13 hereto

Patents. All patents and the patent applications owned or controlled by Zogenix or its Affiliates or MG or its Affiliates at any time during the Term of this Agreement relating to the Device or the Glass Capsules.

Patents. Any document in which Prolexys has one or more rights wherein the document signifies or confers or has the potential (e.g. though filing, prosecution or processing) to signify or confer rights to exclude one or more of making, using, importing, exporting, or selling a product in at least one jurisdiction in the world. "Patents" include any Patent that may issue thereon or therefore and all reissues, extensions, renewals, divisions, and continuations (including continuations-in-part) thereof and... all and foreign counterparts. By way of non-limiting example, "Patents" includes the documents and all foreign counterparts in Exhibits A View More

Patents. Means the Debtors' patents and patent applications, including without limitation the patents and patent applications listed on Schedule E hereto and all continuations, divisionals, provisionals, continuations in part, or reissues of applications related to patents thereon, and (i) all renewals thereof, (ii) all income, royalties, damages and payments now and hereafter due and/or payable under and with respect thereto, subject to payment to any co-owner or inventor of its, his or her share... thereof, including without limitation payments under all licenses entered into in connection therewith and damages and payments for past or future infringements or dilutions thereof, (iii) the right to sue for past, present and future infringements thereof, and (iv) all of the Grantor's rights corresponding thereto throughout the world. For clarification, "Patents" does not include any patents which are currently owned by, and licensed by one or more of the Debtors from, Advanced Cell Technology, Inc., a Delaware corporation. View More

Patents. Shall have the meaning set forth in the Purchase Agreement.

Patents. The patents and patent applications set out in Schedule 1 and any equivalents thereof, and any divisionals, continuations, continuations-in-part, re-filings or re-issues of any of the foregoing, and any other patent applications or patents that would be infringed by manufacture, use or sale of an [***] Vaccine or component thereof

Patents. U.S. Patent 7,405,214B2 and all additional patent applications/patents that may be filed by or for Rexahn covering RX-3117 or any of the Improvements. As of the Effective Date, the Patents include all patents and patent applications listed in Annex 2 attached hereto.

Patents. (i) all patents and patent applications and any patents issuing therefrom worldwide, (ii) any patents and patent applications claiming priority form (i) above, (iii) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates, term extensions (under patent or other law), certificates of invention and the like, of any such patents or patent applications, (iv) any foreign... or international equivalent of any of the foregoing; and (v) any application claiming priority of any patent in (i)-(iv) above View More

Patents. Shall mean (a) United States Patent Nos. 7,351,430 and 7,910,135 in connection with the Product European Patent Application Nos. WO 2004/043438A1 and WO 2008/070270A2. ; Australia Patent No. 10/289,756 and New Zealand Patent No. NZ540571(A), and (b) any and all patents, patent applications, patent disclosures awaiting filing determination, patent divisionals, continuations, continuations-in-part, reissues, re-examinations, renewals and extensions thereof Controlled by ULURU during the Term,... within the Territory, which are necessary for the Manufacture, use or distribution of the Product. View More

Patents. All Patents that issue on parent, continuation and continuation-in-part applications in the same family related to the Field of Use, and foreign counterparts thereto